Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures
NCT00143442 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 184
Last updated 2006-08-08
Summary
The purpose of this study is to determine the effectiveness of \[S,S\]-Reboxetine in the treatment of chronic pain following a shingles infection in patients who are Gabapentin treatment failures.
Conditions
Interventions
- DRUG
-
[S,S]-Reboxetine
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2003-12-31
- Completion
- 2004-10-31
More Related Trials
-
Pilot Study of High-Dose Capsaicin Patches to Treat Postherpetic Neuralgia Pain
NCT00034710 ·Status: COMPLETED ·Phase: PHASE2
-
RN624 For Pain Of Post-Herpetic Neuralgia
NCT00568321 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-Tolerability Titration Study to Evaluate The Efficacy And Safety Of Perampanel (E2007) In Patients With Post-Herpetic Neuralgia (PHN)
NCT00592774 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine if an Investigational Pain Medicine Provides Relief of Chronic Pain After a Shingles Outbreak
NCT00506610 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Comparison of EpiCept™ NP-1 Topical Cream vs. Oral Gabapentin in Postherpetic Neuralgia (PHN)
NCT00475904 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia
NCT01748877 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Of [S,S]-Reboxetine In Patients With Chronic Painful Diabetic Peripheral Neuropathy.
NCT00625833 ·Status: TERMINATED ·Phase: PHASE2
-
A Clinical Trial to Investigate Efficacy and Safety of NT 201 Injections Compared With Placebo Injections in Participants Aged 18 Years and Older With Chronic Nerve Pain After Shingles or Nerve Injury
NCT06091020 ·Status: COMPLETED ·Phase: PHASE2
-
Controlled Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00068081 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Centre, Randomized, Double-Blind, Placebo Controlled Pilot Trial to Assess the Efficacy, Safety, and Tolerability of SPM 927 in Subjects With Postherpetic Neuralgia (PHN).
NCT00861068 ·Status: COMPLETED ·Phase: PHASE2
-
NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00061776 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy and Safety Study of SLC022 in Treating Pain Associated With Post Herpetic Neuralgia
NCT00813826 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia
NCT04662281 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain
NCT01264237 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Sativex® for Pain Relief of Peripheral Neuropathic Pain, Associated With Allodynia
NCT00710554 ·Status: COMPLETED ·Phase: PHASE3
-
Titration Study of ABX-1431
NCT03447756 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of SAR292833 Administration for 4 Weeks in Patients With Chronic Peripheral Neuropathic Pain
NCT01463397 ·Status: COMPLETED ·Phase: PHASE2
-
Study of NGX-4010 for the Treatment of Postherpetic Neuralgia
NCT00300222 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)
NCT00964990 ·Status: TERMINATED ·Phase: PHASE2
-
Evolution of Pain From Herpes Zoster
NCT00305357 ·Status: COMPLETED
-
Duloxetine for PHN
NCT04313335 ·Status: COMPLETED ·Phase: NA
-
P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain
NCT00390845 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Sativex® for Pain Relief Due to Diabetic Neuropathy
NCT00710424 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia
NCT00845923 ·Status: COMPLETED ·Phase: PHASE2
-
A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN)
NCT00576108 ·Status: COMPLETED ·Phase: PHASE2